SkyePharma | Evaluate

September 02, 2016

Snippet roundup: Tecentriq gets lung cancer win, Enbrel biosimilar patent dance intensifies

M&A – Value of deals looks healthy but number meagre

June 20, 2016

Allergy failure lets the cat out of Circassia's M&A bag

April 11, 2016

M&A – without Shaxalta a meagre quarter

March 23, 2016

Event – Circassia’s crucial Catalyst approaches

March 16, 2016

Vectura-SkyePharma merger could be just the start

June 18, 2015

Novartis’s triple push has an unusual target

August 14, 2014

Interview – Unshackled SkyePharma goes hunting

July 16, 2014

Glaxo and Theravance raise the respiratory stakes

April 01, 2014

Biotech’s record-breaking quarter shines spotlight on sustainability

March 31, 2014

With a little help from biotech fever, SkyePharma throws off its albatross

Load More